GATA2 and myelodysplastic syndrome: In order to understand the concept of fertile ground as a driver of MDS/AML in GATA2 deficiency syndromes, more fundamental research is needed to reveal the clonal origin (embryonic and/or adult) of leukemogenic driver mutations to help us choose an appropriate time frame and strategy to treat these patients using genome editing.